GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » EV-to-Revenue

NeoPharm Co (XKRX:092730) EV-to-Revenue : 0.97 (As of May. 22, 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, NeoPharm Co's enterprise value is ₩98,694 Mil. NeoPharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩101,735 Mil. Therefore, NeoPharm Co's EV-to-Revenue for today is 0.97.

The historical rank and industry rank for NeoPharm Co's EV-to-Revenue or its related term are showing as below:

XKRX:092730' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.22   Med: 2.95   Max: 12.59
Current: 0.97

During the past 13 years, the highest EV-to-Revenue of NeoPharm Co was 12.59. The lowest was 0.22. And the median was 2.95.

XKRX:092730's EV-to-Revenue is ranked better than
60.09% of 1879 companies
in the Consumer Packaged Goods industry
Industry Median: 1.18 vs XKRX:092730: 0.97

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), NeoPharm Co's stock price is ₩26950.00. NeoPharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩13,009.79. Therefore, NeoPharm Co's PS Ratio for today is 2.07.


NeoPharm Co EV-to-Revenue Historical Data

The historical data trend for NeoPharm Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co EV-to-Revenue Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.57 1.61 1.02 0.44 0.94

NeoPharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.95 0.82 0.94 0.79

Competitive Comparison of NeoPharm Co's EV-to-Revenue

For the Household & Personal Products subindustry, NeoPharm Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoPharm Co's EV-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, NeoPharm Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where NeoPharm Co's EV-to-Revenue falls into.



NeoPharm Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NeoPharm Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=98693.993/101734.996
=0.97

NeoPharm Co's current Enterprise Value is ₩98,694 Mil.
NeoPharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩101,735 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeoPharm Co  (XKRX:092730) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NeoPharm Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=26950.00/13009.789
=2.07

NeoPharm Co's share price for today is ₩26950.00.
NeoPharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩13,009.79.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeoPharm Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NeoPharm Co (XKRX:092730) Business Description

Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines